B cell-mediated autoimmune diseases and lymphoma can now be treated using antibodies against B cell protein CD20. Antibody binding receptors, called Fc receptors, on other immune cells bind anti-CD20 on coated B cells, which induces B cell deletion through a mechanism that is not clearly understood. In this issue of the iJournal of Clinical Investigation/i, Philippe Bousse and colleagues at the Pasteur Institute in Paris described the fate of B cells in live ...
Read More
No comments:
Post a Comment